These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6150600

  • 1. A comparison of the binding characteristics of the beta-adrenoceptor antagonists 3H-dihydroalprenolol and 125I-iodocyanopindolol in rat liver.
    Sandnes D, Westergren T, Sand TE, Sager G, Refsnes M, Christoffersen T, Jacobsen S.
    Acta Pharmacol Toxicol (Copenh); 1984 Oct; 55(4):287-96. PubMed ID: 6150600
    [Abstract] [Full Text] [Related]

  • 2. Beta-adrenergic receptors in guinea-pig liver plasma membranes and thermal lability of [3H]dihydroalprenolol binding sites.
    Kawai Y, Graham SM, Yoshioka H, Arinze IJ.
    Biochem Pharmacol; 1986 Dec 15; 35(24):4387-93. PubMed ID: 3024648
    [Abstract] [Full Text] [Related]

  • 3. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA, Kellar KJ.
    Mol Pharmacol; 1989 Dec 15; 36(6):903-11. PubMed ID: 2557537
    [Abstract] [Full Text] [Related]

  • 4. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors.
    Neve KA, McGonigle P, Molinoff PB.
    J Pharmacol Exp Ther; 1986 Jul 15; 238(1):46-53. PubMed ID: 3014123
    [Abstract] [Full Text] [Related]

  • 5. Effects of choline and inositol on 3H-dihydroalprenolol and 125I-iodocyanopindolol bindings to beta-adrenergic receptors of the guinea pig cerebral cortical membranes.
    Tsuchihashi H, Nagatomo T.
    Chem Pharm Bull (Tokyo); 1988 Jan 15; 36(1):360-6. PubMed ID: 2837340
    [No Abstract] [Full Text] [Related]

  • 6. Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes.
    Kawai Y, Powell A, Arinze IJ.
    J Clin Endocrinol Metab; 1986 May 15; 62(5):827-32. PubMed ID: 3007555
    [Abstract] [Full Text] [Related]

  • 7. Uptake of L-[propyl-2,3-3H]dihydroalprenolol by intact HeLa cells.
    Meier KE, Ruoho AE.
    Biochim Biophys Acta; 1984 Jul 20; 804(3):331-40. PubMed ID: 6146352
    [Abstract] [Full Text] [Related]

  • 8. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
    Kitagawa Y, Adachi-Akahane S, Nagao T.
    Br J Pharmacol; 1995 Sep 20; 116(1):1635-43. PubMed ID: 8564230
    [Abstract] [Full Text] [Related]

  • 9. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA, Creese I.
    Mol Pharmacol; 1989 Jul 20; 36(1):201-10. PubMed ID: 2546050
    [Abstract] [Full Text] [Related]

  • 10. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
    Sawutz DG, Sylvestre D, Homcy CJ.
    J Immunol; 1985 Oct 20; 135(4):2713-8. PubMed ID: 2993414
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of adrenoceptors and [3H]nitrendipine receptors of porcine vascular smooth muscle: differences between coronary artery and aorta.
    Nishimura J, Kanaide H, Nakamura M.
    Circ Res; 1987 Jun 20; 60(6):837-44. PubMed ID: 3036396
    [Abstract] [Full Text] [Related]

  • 12. Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.
    Roberts SJ, Molenaar P, Summers RJ.
    Br J Pharmacol; 1993 Jun 20; 109(2):344-52. PubMed ID: 8102926
    [Abstract] [Full Text] [Related]

  • 13. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.
    Sillence MN, Moore NG, Pegg GG, Lindsay DB.
    Br J Pharmacol; 1993 Aug 20; 109(4):1157-63. PubMed ID: 8104645
    [Abstract] [Full Text] [Related]

  • 14. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
    Landi M, Bianchetti A, Croci T, Manara L.
    Biochem Pharmacol; 1992 Aug 18; 44(4):665-72. PubMed ID: 1354964
    [Abstract] [Full Text] [Related]

  • 15. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D, Engel G, Kalkman HO.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):13-23. PubMed ID: 2935410
    [Abstract] [Full Text] [Related]

  • 16. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.
    Chang RS, Lotti VJ.
    Life Sci; 1983 May 30; 32(22):2603-9. PubMed ID: 6134224
    [Abstract] [Full Text] [Related]

  • 17. Adipocyte beta-adrenergic receptors. Identification and subcellular localization by (-)-[3H]dihydroalprenolol binding.
    Williams LT, Jarett L, Lefkowitz RJ.
    J Biol Chem; 1976 May 25; 251(10):3096-104. PubMed ID: 942608
    [Abstract] [Full Text] [Related]

  • 18. The (--)[3H]dihydroalprenolol binding to rat adipocyte membranes: an explanation of curvilinear Scatchard plots and implications for quantitation of beta-adrenergic sites.
    Dax EM, Partilla JS, Gregerman RI.
    J Lipid Res; 1982 Sep 25; 23(7):1001-8. PubMed ID: 6292316
    [Abstract] [Full Text] [Related]

  • 19. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
    Matsumoto I, Combs MR, Jones DJ.
    J Pharmacol Exp Ther; 1992 Feb 25; 260(2):614-26. PubMed ID: 1738111
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
    Tsuchihashi H, Nakashima Y, Kinami J, Nagatomo T.
    Jpn J Pharmacol; 1990 Feb 25; 52(2):195-200. PubMed ID: 1968985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.